Asian Spectator


The Times

.

FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US

  • Written by PR Newswire Asia - Asian Spectator

HIGHLIGHTS

  • The US FDA has cleared Amplia's Investigational New Drug (IND) Application for a clinical trial of narmafotinib in the USA
  • The proposed trial would explore the combination of narmafotinib and FOLFIRINOX in advanced pancreatic cancer patients in the USA

MELBOURNE, Australia, Jan. 18, 2024 /PRNewswire/ -- Amplia Therapeutics...

Magazine

Why Early Protection of Intellectual Assets is Critical

For many businesses, intellectual assets are among the most valuable things they own, yet they're often the last to receive formal legal protection. A brand name or a proprietary process can represe...

Konservasi gaya lama tak efektif: Pemulihan Aceh perlu warga dengan ekonomi yang merawat hutan

shutterstock(Manthofana/Shutterstock)● Peminggiran warga dari konservasi hutan Lingga Isaq menjadi salah satu faktor yang memperparah dampak bencana.● Pertanian monokultur dan tambang emas...

Tanggal kedaluwarsa produk kosmetik bukan akal-akalan ‘marketing’: Ada standar ilmiah di baliknya

● Tanggal kedaluwarsa menunjukkan batas waktu resmi sebuah produk masih dapat digunakan.● Period after opening (PAO) menandakan batas waktu aman produk boleh digunakan sejak kemasannya dib...

hacklink hack forum hacklink film izle hacklink testbets10sahabetMeritbetagb99Meritbetgrandpashabetefesbetcasinocasibom güncel girişzlibraryVikings İzlepokerklasTaraftarium24deneme bonusujojobetjojobetcasibombetparkjojobetJojobet